Real-world study tracks how IBD treatment goals are met in clinics worldwide

NCT ID NCT07421258

Recruiting now Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observes how doctors use a treat-to-target strategy for people with Crohn's disease or ulcerative colitis in routine care. Researchers will review medical records of 2000 adults over 24 months to see if adjusting treatment based on disease activity improves outcomes. No extra visits or tests are required for participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN'S DISEASE ULCERATIVE COLITIS

Contacts and locations

Locations

CHU Amiens-Picardie Site Sud /ID# 280263
NOT_YET_RECRUITING

Amiens, Somme, 80054, France
Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois /ID# 280265
NOT_YET_RECRUITING

Vandœuvre-lès-Nancy, Meurthe-et-Moselle, 54511, France
Centre Hospitalier Universitaire de Nîmes - Hôpital Universitaire Carémeau /ID# 282775
NOT_YET_RECRUITING

Nîmes, Gard, 30029, France
Chongqing General Hospital /ID# 282777
RECRUITING

Chongqing, Chongqing Municipality, 400013, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.